Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of potential gene signatures associated with osteosarcoma by integrated bioinformatics analysis. | PeerJ | 2021 | 34123594 | PubTator, text mining | PubMed |
| Development and Validation of a Novel Metabolic-Related Signature Predicting Overall Survival for Pancreatic Cancer. | Front Genet | 2021 | 34122496 | PubTator, text mining | PubMed |
| Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics. | Cancer Med | 2021 | 34121365 | PubTator, text mining | PubMed |
| Evaluation of population-level pharmacogenetic actionability in Alabama. | Clin Transl Sci | 2021 | 34121327 | PubTator, text mining | PubMed |
| Impact of skeletal muscle mass in patients with recurrent gastric cancer. | World J Surg Oncol | 2021 | 34116681 | PubTator, text mining | PubMed |
| Analytical validation of a laboratory-development multigene pharmacogenetic assay. | Pharmacogenet Genomics | 2021 | 34116532 | PubTator, text mining | PubMed |
| Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer. | PLoS One | 2021 | 34101751 | PubTator, text mining | PubMed |
| Development of an Immune-Related Prognostic Index Associated With Glioblastoma. | Front Neurol | 2021 | 34093386 | PubTator, text mining | PubMed |
| Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene Variation. | Clin Pharmacol Ther | 2021 | 34091888 | PubTator, text mining | PubMed |
| Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets. | Science | 2021 | 34083449 | PubTator, text mining | PubMed |
| Pharmacogenomic-based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare system. | Clin Transl Sci | 2021 | 34080317 | PubTator, text mining | PubMed |
| Interactions between cardiology and oncology drugs in precision cardio-oncology. | Clin Sci (Lond) | 2021 | 34076246 | PubTator, text mining | PubMed |
| Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019. | Curr Oncol | 2021 | 34073199 | PubTator, text mining | PubMed |
| Genetic Predisposition to the Mortality in Septic Shock Patients: From GWAS to the Identification of a Regulatory Variant Modulating the Activity of a CISH Enhancer. | Int J Mol Sci | 2021 | 34072601 | PubTator, text mining | PubMed |
| An Example of Personalized Treatment in HR+ HER2+ Long Survivor Breast Cancer Patient (Case Report). | Curr Oncol | 2021 | 34070464 | PubTator, text mining | PubMed |
| Bio- and Hemo-Compatible Silk Fibroin PEGylated Nanocarriers for 5-Fluorouracil Chemotherapy in Colorectal Cancer: In Vitro Studies. | Pharmaceutics | 2021 | 34069731 | PubTator, text mining | PubMed |
| Force Field Parameters for Fe2+4S2-4 Clusters of Dihydropyrimidine Dehydrogenase, the 5-Fluorouracil Cancer Drug Deactivation Protein: A Step towards In Silico Pharmacogenomics Studies. | Molecules | 2021 | 34069161 | PubTator, text mining | PubMed |
| Current Landscape in Organic Nanosized Materials Advances for Improved Management of Colorectal Cancer Patients. | Materials (Basel) | 2021 | 34066710 | PubTator, text mining | PubMed |
| The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug-Drug Interactions: Drug-Gene, Drug-Gene-Gene and Drug-Drug-Gene Interactions. | Pharmaceuticals (Basel) | 2021 | 34065361 | PubTator, text mining | PubMed |
| KRAS, A Prime Mediator in Pancreatic Lipid Synthesis through Extra Mitochondrial Glutamine and Citrate Metabolism. | Int J Mol Sci | 2021 | 34064761 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=61